Regeneron Pharmaceuticals Inc (REGN)
Debt-to-capital ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 30,957,800 | 29,938,900 | 29,387,600 | 29,353,600 | 29,325,900 | 28,205,800 | 26,991,100 | 25,973,100 | 24,904,400 | 24,017,900 | 23,495,200 | 22,664,000 | 21,438,800 | 20,687,800 | 19,914,700 | 18,768,800 | 17,258,000 | 15,127,300 | 11,977,000 | 11,025,300 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
September 30, 2025 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $30,957,800K)
= 0.00
Peer comparison
Sep 30, 2025
Company name
Symbol
Debt-to-capital ratio
Regeneron Pharmaceuticals Inc
REGN
0.00
Arrowhead Pharmaceuticals Inc
ARWR
0.00
Biomarin Pharmaceutical Inc
BMRN
0.00
See also:
Regeneron Pharmaceuticals Inc Debt to Capital (Quarterly Data)